Biosynthesis of Prostaglandins and Thromboxanes

  • Elisabeth Granström
Part of the NATO Advanced Study Institutes Series book series


The biosynthesis of the prostaglandins, and later also the thromboxanes, from polyunsaturated fatty acids has been the subject of a vast number of studies since the mid -60’s (see 1, 2 and references therein). When the identification of the precursor fatty acids was made (3,4), it became obvious that the “prostaglandin synthetase” must be a multienzyme complex. How complicated this area actually is has become increasingly evident during the last decade with the discoveries of several new compounds and pathways (2).


Arachidonic Acid Prostaglandin Biosynthesis Precursor Fatty Acid Prostaglandin Endoperoxide DEAE Cellulose Chromatography 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    B. Samuelsson, E. Granström, K. Green, M. Hamberg and S. Hammarström, Prostaglandins. Ann. Rev. Biochem., 44: 669 (1975).PubMedCrossRefGoogle Scholar
  2. 2.
    B. Samuelsson, M. Goldyne, E. Granström, M. Hamberg, S. Hammarström and C. Malmsten, Prostaglandins and thromboxanes. Ann. Rev. Biochem. 47: 997 (1978).PubMedCrossRefGoogle Scholar
  3. 3.
    D. A. Van Dorp, R. K. Beerthuis, D. H. Nugteren and H. Vonkeman, The biosynthesis of prostaglandins. Biochim. Biophys. Acta, 90: 204 (1964).CrossRefGoogle Scholar
  4. 4.
    S. Bergstrom, H. Danielsson and B. Samuelsson, The enzymatic formation of prostaglandin E2 from arachidonic acid. Biochim. Biophys. Acta, 90: 207 (1964).CrossRefGoogle Scholar
  5. 5.
    M. Hamberg and B. Samuelsson, Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis Proc. Natl. Acad. Sci. USA, 70: 899 (1973).CrossRefGoogle Scholar
  6. 6.
    D. H. Nugteren and E. Hazelhof, Isolation and properties of intermediates in prostaglandin biosynthesis. Biochim. Biophys. Acta, 326: 448 (1973).PubMedCrossRefGoogle Scholar
  7. 7.
    M. Hamberg, J. Svensson, T. Wakabayashi and B. Samuelsson, Isolation and structure of two prostaglanding endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. USA, 71: 345 (1974).PubMedCrossRefGoogle Scholar
  8. 8.
    T. Miyamoto, N. Ogino, S. Yamamoto and 0. Hayaishi, Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem., 251: 2629 (1976).Google Scholar
  9. 9.
    M. Hemler, W. E. M. Lands and W. L. Smith, Purification of the cyclo-oxygenase that forms prostaglandins: Demonstration of two forms of iron in the holoenzyme. J. Biol. Chem., 251: 5575 (1976).PubMedGoogle Scholar
  10. 10.
    F. J. van der Ouderaa, M. Buytenhek, D. H. Nugteren and D. A. van Dorp, Purification and characterization of prostaglandin endoperoxide synthetase from sheep vesicular glands. Biochim. Biophys. Acta., 487: 315 (1977).PubMedCrossRefGoogle Scholar
  11. 11.
    G. J. Roth, M. Stanford, J. W. Jacobs and P. W. Majerus, Acetylation of prostaglandin synthetase by aspirin. Purification and properties of the acetylated protein from sheep vesicular gland. Biochemistry, 16: 4244 (1977).PubMedCrossRefGoogle Scholar
  12. 12.
    G. J. Roth and P. W. Majerus, The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J. Clin. Invest., 56: 624 (1975).CrossRefGoogle Scholar
  13. 13.
    F. J. van der Ouderaa, M. Buytenhek. F. J. Slikkerveer and D. A. van Dorp, On the haemoprotein character of prostaglandin endoperoxide synthetase. Biochim. Biophys. Acta., 572: 29 (1979).PubMedCrossRefGoogle Scholar
  14. 14.
    S. Okhi, N. Ogino, S. Yamamoto and O. Hayaishi, Prostaglandin hydroperoxides, an integral part of prostaglandin endoperoxide synthetase from bovine gland microsomes. J. Biol. Chem., 254: 829 (1979).Google Scholar
  15. 15.
    N. Ogino, S. Ohki, S. Yamamoto and O. Hayaishi, Prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. Inactivation and activation by heure and other metalloporphyrins. J. Biol. Chem. 253: 5061 (1978).PubMedGoogle Scholar
  16. 16.
    R. W. Egan, P. H. Gale and F. A. Kuehl, Jr., Reduction of hydroperoxides in the prostaglandin biosynthetic pathway by a microsomal peroxidase. J. Biol. Chem. 254: 3295 (1979).PubMedGoogle Scholar
  17. 17.
    C. J. Sih, C. Takeguchi and P. Foss, Mechanism of prostaglandin biosynthesis. III. Catecholamines and serotonin as coenzymes. J. Am. Chem. Soc., 92: 6670 (1970).PubMedCrossRefGoogle Scholar
  18. 18.
    N. Ogino, S. Yamamoto, 0. Hayaishi and T. Tokuyama, Isolation of an activator for prostaglandin hydroperoxidase from bovine vesicular gland cytosol and its identification as uric acid. Biochem. Biophys. Res. Commun. 87: 184 (1979).Google Scholar
  19. 19.
    M. Ogino, T. Miyamoto, S. Yamamoto and 0. Hayaishi, Prostglandin endoperoxide E-isomerase from bovine vesicular gland microsomes, a glutathione-requiring enzyme. J. Biol. Chem., 252: 890 (1977).Google Scholar
  20. 20.
    A. Raz, M. Schwartzman and R. Kenig-Wakshal, Chemical and enzymatic transformations of prostaglandin endoperoxides: Evidence for the predominance of the 15-hydroperoxy pathway Eur. J. Biochem., 70: 89 (1976).PubMedCrossRefGoogle Scholar
  21. 21.
    D. H. Nugteren and E. Christ-Hazelhof, Chemical and enzymic conversion of the prostaglandin endoperoxide H2. In: “Advances in Prostaglandin and Thromboxane Research” B. Samuelsson, P. Ramwell and R. Paoletti, eds., Raven Press, New York. In press (1980).Google Scholar
  22. 22.
    J. B. Smith, M. J. Silver, C. M. Ingerman and J. J. Kocsis, Prostaglandin D2 inhibits the aggregation of human platelets. Thromb. Res., 5: 291 (1974).PubMedCrossRefGoogle Scholar
  23. 23.
    M. Hamberg, P. Hedqvist, K. Strandberg, J. Svensson and B. Samuelsson, Prostaglandin endoperoxides IV. Effects on smooth muscle. Life Sci. 16: 451 (1975).PubMedCrossRefGoogle Scholar
  24. 24.
    M. A. Wasserman, D. W. Ducharme, R. L. Griffin, G. L. de Graaf and F. G. Robinson, Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog. Prostaglandins, 13: 255 (1977).PubMedGoogle Scholar
  25. 25.
    M. 0. Whitaker, P. Needleman, A. Wyche, F. A. Fitzpatrick and H. Sprecher, PGD3 is the mediator of the antiaggregatory effects of the trienoic endoperoxide PGH3. In: “Advances in Prostaglandin and Thromboxane Research” B. Samuelsson, P. Ramwell and R. Paoletti. Raven Press, New York. In press (1980).Google Scholar
  26. 26.
    M. S. Abdel-Halim, M. Hamberg, B. Sjöqvist and E. Anggârd, Identification of prostaglandin D2 as a major prostaglandin in homogenates of rat brain. Prostaglandins, 14:633 (1977).Google Scholar
  27. 27.
    L. J. Roberts, R. A. Lewis, J. A. Lawson, B. J. Sweetman K. F. Austen and J. A. Oates Arachidonic acid metabolism by rat mast cells. Prostaglandins, 15:717 (1978).Google Scholar
  28. 28.
    H. R. Knapp. 0. Oelz, B. J. Sweetman and J. A. Oates, Synthesis and metabolism of prostaglandins E2, F2 and D2 by the rat gastrointestinal tract. Stimulation by a hypertonic environment in vitro. Prostaglandins, 15: 751 (1978).Google Scholar
  29. 29.
    F. A. Fitzpatrick and D. A. Stringfellow, Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential. Proc. Natl. Acad. Sci. USA, 76: 1765 (1979).PubMedCrossRefGoogle Scholar
  30. 30.
    M. Hamberg and B. Fredholm, Isomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin. Biochim. Biophys. Acta, 431: 189 (1976).PubMedCrossRefGoogle Scholar
  31. 31.
    E. Christ-Hazelhof, D. H. Nugteren and D. A. van Dorp, Conversion of prostaglandin endoperoxides by glutathione S-transferases and serum albumins. Biochim. Biophys. Acta, 450: 450 (1976).PubMedCrossRefGoogle Scholar
  32. 32.
    D. A. van Dorp, M. Buytenhek, E. Christ-Hazelhof, D. H. Nugteren and F. J. van der Ouderaa, Isolation and properties of enzymes involved in prostaglandin synthesis. Acta Biol. Med. Germ., 37: 691 (1978).Google Scholar
  33. 33.
    E. Christ-Hazelhof and D. H. Negteren, Purification and characterization of prostaglandin endoperoxide D-isomerase, a cytoplasmic glutatione-requiring enzyme. Biochim. Biophys. Acta, 572: 43 (1979).PubMedCrossRefGoogle Scholar
  34. 34.
    T. Shimizu, S. Yamamoto and 0. Hayaishi, Purification and properties of prostaglandin D synthetase from rat brain. J. Biol. Chem., 254: 5222 (1979).Google Scholar
  35. 35.
    J. A. McCracken, J. C. Carlson, M. E. Glew, J. R. Godin, D. T. Baird, K. Green and B. Samuelsson, Prostaglandin F2a identified as a luteolytic hormone in sheep. Nature (New Biol.) 238: 129 (1972).CrossRefGoogle Scholar
  36. 36.
    G. D. Thorburn, R. I. Cox, W. B. Currie, B. J. Restall and W. Schneider, Prostaglandin F concentration in the utero-ovarian venous plasma of the ewe during the estrus cycle. J. Endocrinol., 53: 325 (1972).PubMedCrossRefGoogle Scholar
  37. 37.
    H. Kindahl, L.-E. Edqvist, A. Bane and E. Granström, Blood levels of progesterone and 15-keto-13,14-dihydro-prostaglandin F2 during the normal oestrous cycle and early pregancy in heifers. Acta Endocrin. (Kbh.) 82: 134 (1976).Google Scholar
  38. 38.
    P. Wlodawer, H. Kindahl and M. Hamberg, Biosynthesis of prostaglandin F from arachidonic acid and prostaglandin endoperoxides in the uterus. Biochim. Biophys.. Acta., 431: 603 (1976).PubMedCrossRefGoogle Scholar
  39. 39.
    M. Hamberg, J. Svensson and B. Samuelsson, Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. USA, 72: 2994 (1975).PubMedCrossRefGoogle Scholar
  40. 40.
    M. Hamberg and B. Samuelsson, Prostaglandin endoperoxides VII. Novel transformations of arachidonic acid in guinea pig lung. Biochem. Biophys. Res. Commun., 61: 942 (1974).PubMedCrossRefGoogle Scholar
  41. 41.
    T. Yoshimoto, S. Yamamoto, M. Okuma and 0. Hayaishi, Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets. J. Biol. Chem., 252: 5871 (1977).Google Scholar
  42. 42.
    S. Hammarström and P. Falardeau, Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets. Proc. Natl. Acad. Sci. USA, 74: 3691 (1977).PubMedCrossRefGoogle Scholar
  43. 43.
    P. Wlodawer and S. Hammarström, Thromboxane synthase from bovine lung-solubilization and partial purification. Biochem. Biophys. Res. Commun., 80: 525 (1978).PubMedCrossRefGoogle Scholar
  44. 44.
    U. Diczfalusy, P. Falardeau and S. Hammarström, Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase. FEBS Lett., 84: 271 (1977).PubMedCrossRefGoogle Scholar
  45. 45.
    M. W. Anderson, D. J. Crutchley, B. E. Tainer and T. E. Eling, Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase. Prostaglandins, 16: 563 (1978).PubMedGoogle Scholar
  46. 46.
    P. Needleman, H. Minkes and A. Raz, Thromboxanes: Selective biosynthesis and distinct biological properties. Science, 193: 163 (1976).PubMedCrossRefGoogle Scholar
  47. 47.
    U. Diczfalusy and S. Hammarström, A structural requirement for the conversion of prostaglandin endoperoxides to thromboxanes. FEBS Lett., 105: 291 (1979).PubMedCrossRefGoogle Scholar
  48. 48.
    S. Hammarström, Enzymatic synthesis of 15-hydroperoxythromboxane A2 and 12-hydroperoxy-5, 8, 10-heptadecatrienoic acid. J. Biol. Chem., in press (1979).Google Scholar
  49. 49.
    S. Moncada, R. J. Gryglewski, S. Bunting and J. R. Vane, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature, 263: 663 (1976).PubMedCrossRefGoogle Scholar
  50. 50.
    R. J. Gryglewski, S. Bunting, S. Moncada, R. J. Flower and J. R. Vane, Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins 12: 685 (1976).PubMedGoogle Scholar
  51. 51.
    F. C. Huang, M. Zmijewski, G. Girdaukas and C. J. Sih, Concerning the biosynthesis of prostaglandin I2.Bioorganic Chem., 6: 311 (1977).CrossRefGoogle Scholar
  52. 52.
    P. Wlodawer and S. Hammarstróm, Some properties of prostacyclin synthase from pig aorta. FEBS Lett., 97: 32 (1979).PubMedCrossRefGoogle Scholar
  53. 53.
    K. Watanabe, S. Yamamoto and O. Hayaishi, Reactions of prostaglandin endoperoxides with prostaglandin I synthetase solubilized from rabbit aorta microsomes. Biochem. Biophys. Res. Commun., 87: 192 (1979).PubMedCrossRefGoogle Scholar
  54. 54.
    S. Moncada, R. J. Gryglewski, S. Bunting and J. R. Vane, A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins, 12: 715 (1976).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • Elisabeth Granström
    • 1
  1. 1.Department of ChemistryKarolinska InstitutetSweden

Personalised recommendations